Key Highlights

  • Nasdaq granted Datavault AI a further 180 days, to 22 February 2027, to regain compliance with the minimum bid price requirement.
  • Second-quarter 2026 Revenue was USD 6.7 million, up 287 per cent, while the net loss was USD 88.0 million.
  • Cash was USD 1.4 million at 30 June, and the company signed a non-binding letter of intent to acquire a 19.9 per cent stake in DataMEDS AI.

A listing deadline extended

Datavault AI Inc. (NASDAQ:DVLT) describes itself as an artificial intelligence platform for data monetisation and real-world asset tokenisation. Its common stock trades on the Nasdaq Capital Market, and its shares have traded below 1 dollar for months, which is the central issue for its listing status.

According to a Form 8-K dated 25 August 2026, Nasdaq notified the company on 24 February 2026 that its stock had closed below 1 dollar for 30 consecutive Business days. The company missed the first compliance deadline of 24 August, but Nasdaq granted a further 180 calendar days, to 22 February 2027.

Regaining compliance requires a closing bid of at least 1 dollar for ten consecutive business days. The company said it would cure the deficiency, including by a Reverse Stock Split if necessary, though the filing announced no split. If it fails, Nasdaq could issue a delisting notice, which the company could appeal to a hearings panel without any assurance of success.

Latest reported results

The most recent reported quarter is the second quarter of 2026, announced on 19 August. Revenue was 6.7 million dollars, up 287 per cent from 1.7 million a year earlier, and Gross Profit was 2.9 million dollars. Six-month revenue was 10.1 million dollars.

The net loss was 88.0 million dollars, or 0.12 dollars per share, against 37.1 million a year earlier. The company attributed much of the loss to a 56.4 million dollar Impairment on non-marketable securities and an 8.1 million dollar loss on crypto assets. The six-month net loss was 141.2 million dollars.

Cash and cash equivalents were 1.4 million dollars at 30 June, while the Balance Sheet also listed 49.0 million dollars of crypto assets. Management reiterated a target of at least 200 million dollars of 2026 revenue. That is a goal, not a result, and it compares with 10.1 million dollars reported for the first half.

Recent corporate announcements

On 22 October the company announced a non-binding letter of intent to acquire a 19.9 per cent fully diluted Equity stake in DataMEDS AI, Inc. in return for an expanded technology licence. The proposal contemplates a board seat and a share in royalties from commercialisation. Completion depends on due diligence, definitive agreements and approvals, and management said a fourth-quarter 2026 closing is realistic.

Because the letter is non-binding, neither party is obliged to complete the transaction. It should be treated only as a proposal rather than a concluded deal.

The structure is also worth noting: Datavault would pay for the equity stake by expanding a licence rather than with cash, which matters for a company reporting only 1.4 million dollars of cash. The effect on reported Earnings would depend on how the stake is valued, which the announcement does not specify.

What to watch

Several dated and measurable items matter. The first is the 22 February 2027 compliance deadline and whether the company seeks Shareholder approval for a reverse split. The second is liquidity, given 1.4 million dollars at the end of June and substantial operating cash use during the first half. The third is whether the DataMEDS letter turns into a definitive agreement. The fourth is how quarterly revenue compares with the 200 million dollar annual target.